TrianglePUBLICATIONS · 23715577
Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Jul 1
- First author
- Zwaan CM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zwaan CM
- type
- Author
- name
- Rizzari C
- type
- Author
- name
- Mechinaud F
- type
- Author
- name
- Lancaster DL
- type
- Author
- name
- Lehrnbecher T
- type
- Author
- name
- van der Velden VH
- type
- Author
- name
- Beverloo BB
- type
- Author
- name
- den Boer ML
- type
- Author
- name
- Pieters R
- type
- Author
- name
- Reinhardt D
- type
- Author
- name
- Dworzak M
- type
- Author
- name
- Rosenberg J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zwaan CM
- type
- Author
- name
- Rizzari C
- type
- Author
- name
- Mechinaud F
- type
- Author
- name
- Lancaster DL
- type
- Author
- name
- Lehrnbecher T
- type
- Author
- name
- van der Velden VH
- type
- Author
- name
- Beverloo BB
- type
- Author
- name
- den Boer ML
- type
- Author
- name
- Pieters R
- type
- Author
- name
- Reinhardt D
- type
- Author
- name
- Dworzak M
- type
- Author
- name
- Rosenberg J
- type
- Author
- bibliography ids
- nci-bib-4fd9426c5ae467418d189e1a
- book metadata
- content sha256
- a1375ed78c88e62ced5464120712340e27f6a4fda8b09314b970caf2d65ccede
- document type
- citation
- dois
- 10.1200/JCO.2012.46.8280
- electronic publication date
- display
- 2013 May 28
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23715577
- immutable id
- pubmed:23715577@a1375ed78c88e62ced5464120712340e27f6a4fda8b09314b970caf2d65ccede
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2460-8
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23715577
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- e47edb1f8311d0231d498288bd52c5049dd7dcb1e9fb98b2c08879e3f10bd25b
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Jul 1
- precision
- day
- year
- 2013
- publication types
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.
Preserved source evidence · Not medical advice